|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 17, 2018 ) Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. The harmful consequences of Ebola viral infection are that the viruses can be used as potential biological weapon. The symptoms of Ebola viral infection include sudden onset of fever, sore throat, headaches, extreme tiredness, vomiting, skin rash, muscular pain, etc. Ebola virus causes haemorrhagic fever which may lead to internal or external bleeding. The symptoms appear anywhere from 2 to 21 days after exposure to Ebola, though the average is 8 to 10 days. Diagnostic tests are now being done by ELISA (Antigen-capture enzyme-linked immunosorbent assay), Polymerase Chain Reaction, Virus Location, IgM Elisa and Immunohistochemistry testing. Few vaccines and medical treatments for Ebola are in pipeline and due to the absence of effective treatments, the pharmaceutical companies now have big opportunities in the market globally. As per WHO, several care rehydration methods are adopted with fluid injection orally and other treatments are also taken care of which improves the survival rate. Top drug companies such as Hemispherx Biopharma, Biochryst Pharmaceuticals, Nano Vircides, Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceuticals are among the key players in the global Ebola treatment market and are conducting trials on a set of experimental drugs.
Get More Information about this report at http://www.orbisresearch.com/contacts/request-sample/2320235
The global Ebola treatment market growth is driven by the increasing incidence rates of Ebola viral infection and Ebola outbreaks. As per WHO, U.S. & U.K. governments, availability of different treatment procedures to treat Ebola is expected to drive the Ebola viral disease market growth during the forecast period. The Ebola treatment market also includes therapies for those who already have Ebola, and vaccines to prevent the deadly virus. Various drug companies and regulators in the U.S. are taking a two-pronged approach in finding a way to treat the virus. Approval of vaccines are taking a longer time but when vaccines undergo trials, adoption and availability could be a limiting factor for global Ebola treatment market growth.
In 2017, the global Ebola Treatment market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Ebola Treatment market based on company, product type, application and key regions.
The various contributors involved in the value chain of Ebola Treatment include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Ebola Treatment include
Arbutus Biopharma
GlaxoSmithKline
Johnson & Johnson Services
herx Biopharma
BioCryst Pharmaceuticals
NanoViricides
NewLink Genetics
Chimerix
Sarepta Therapeutics
Mapp Biopharmaceutical
Market Size Split by Type
Vaccine (Under Trials)
Drugs (Under Trials)
Market Size Split by Application
Hospitals
Ambulatory Surgery Centres
Specialized Clinics
Army Camps (Veteran Facilities)
The study objectives of this report are:
To study and analyze the global Ebola Treatment market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Ebola Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ebola Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Ebola Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Ebola Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Make an Inquiry before Buying@ http://www.orbisresearch.com/contacts/enquiry-before-buying/2320235
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Orbis Research
Hector Costello
+1 (214) 884-6817
sales@orbisresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
